2005 Miami Breast Cancer Conference

Posters

1. Cancer Trials Support Unit and Central Institutional Review Board
2. Controversies in HER2 Testing
3. Chemoprevention and Management of DCIS
4. Neoadjuvant Chemotherapy
5. Neoadjuvant Endocrine Therapy
6. Neoadjuvant Trials of Trastuzumab in HER2-Positive Breast Cancer
7. Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trial
8. Sequential Adjuvant Hormonal Therapy Following Tamoxifen
9. Adjuvant Endocrine Therapy Trials in Premenopausal Patients
10. Research To Practice: Adjuvant Endocrine Therapy
11. Optimizing Adjuvant Chemotherapy: Ongoing Trials and Recent Results
12. CALGB-49907: Adjuvant Chemotherapy in Elderly Women
13. Clinical Trials of Adjuvant Trastuzumab
14. Trials of Hormonal Therapy in Metastatic Disease
15. Sequencing of Hormonal Therapies in Metastatic Disease
16. Patient Perspectives on Endocrine Therapy for Metastatic Disease
17. Chemotherapy for Metastatic Disease
18. Research To Practice: Chemotherapy in Metastatic Disease
19. Targeting the HER Pathways
20. Research To Practice: HER2-Positive Disease
21. Partial Breast Irradiation for Primary Breast Cancer
22. Management of the Axilla
23. Antiangiogenic Therapy
24. Adjuvant Bisphosphonates
25. Predicting Prognosis in Women with Early Breast Cancer
26. Impact of CME on Practice Patterns in Breast Cancer

Download all